about
Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleasesThe origin of the Haitian cholera outbreak strainMucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motilityDevelopment of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry.Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypesMaximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.Vibrio cholerae-induced inflammation in the neonatal mouse cholera modelGenetically modified organisms and visceral leishmaniasisReactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins.Attenuation of bacterial virulence by quorum sensing-regulated lysis.Vibrio cholerae: lessons for mucosal vaccine design.Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans.Natural cholera infection-derived immunity in an endemic settingTranscutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.Combination vaccines against diarrheal diseases.Production and sequence validation of a complete full length ORF collection for the pathogenic bacterium Vibrio cholerae.Present and future cholera vaccines.Proteomic analysis of Vibrio cholerae in human stool.Needle-free vaccine delivery.Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1.Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.Molecular and biopharmaceutical investigation of alginate-inulin synbiotic coencapsulation of probiotic to target the colon.Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model.Cholera
P2860
Q27333153-204856AB-8900-4235-AAE9-4CD040EE83B6Q28300132-40B49B94-6462-41DB-9C15-4D44E18A2A75Q30496874-306D38A2-48BA-4428-A345-1469B69659B1Q33299645-5C6CD42E-6812-4229-AB68-2330A61A06E6Q33434271-BFF5160D-10AE-4507-B518-F6B3D0B3EE20Q33578033-AFCDC46F-5247-4EBF-AD5C-1D4C1A342041Q33602997-F0BA088C-0B85-43E0-89D4-B8E6A82A26CEQ33647026-E496D070-239F-4FD4-B13C-58CDF4A5F755Q33732959-938057AB-75FB-406D-A7D4-DE9C03CDDD58Q34281775-71687625-CDDE-4F96-8B74-268CE9AB9F85Q34562952-9A109D8E-1E38-470F-9820-3F452BA39728Q35066200-31D3EC62-0EF8-4244-9DFF-F66293F58BCEQ35138715-C9D1E58A-F29A-435A-A2A9-EC004BCE553FQ35167097-AA33D843-E657-4F00-97EE-2BC2AF99BD3CQ35867213-EA73B86B-EB7F-4345-B7D0-4CB82CF67A82Q35896237-67B98DD7-FC5C-4027-A3CE-33F8720B3011Q36670147-6B1DF44D-378E-4930-AA56-CCF7A2F8F30DQ36690265-D4FD2F22-EC11-43E2-B0EE-A1E0A096B3CBQ36845320-0DE1E8B1-B416-4D76-A1BF-ECB08813D5C5Q36945838-A9A747A8-0900-4FE2-AC30-FBE24F660ABFQ36970778-EFE80452-F59B-4BB4-A4E2-B1812549DDB5Q37206031-6A625F63-4442-4A72-BDD3-351717B70774Q37640110-ADF4E31C-2588-4226-AA3F-D3C720460375Q40270533-58F42A29-13C3-4E9B-9C65-E66DE1E7BA5CQ46125947-6A891779-487B-490A-BD4C-0DF57C4B4FF7Q55890255-F00A77AA-9C46-4E38-A7DF-727DDCC8D042
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Live attenuated oral cholera vaccines.
@ast
Live attenuated oral cholera vaccines.
@en
type
label
Live attenuated oral cholera vaccines.
@ast
Live attenuated oral cholera vaccines.
@en
prefLabel
Live attenuated oral cholera vaccines.
@ast
Live attenuated oral cholera vaccines.
@en
P2860
P356
P1476
Live attenuated oral cholera vaccines.
@en
P2093
Edward T Ryan
Stephen B Calderwood
P2860
P304
P356
10.1586/14760584.5.4.483
P577
2006-08-01T00:00:00Z